Full Text View
Tabular View
No Study Results Posted
Related Studies
Diffusion-Weighted Magnetic Resonance Imaging in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
This study is not yet open for participant recruitment.
Verified September 2012 by National Cancer Institute (NCI)
Study NCT01564368   Information provided by National Cancer Institute (NCI)

First Received on March 24, 2012.   Last Updated on September 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
cyclophosphamide
doxorubicin hydrochloride
paclitaxel
imaging biomarker analysis
breast imaging study
neoadjuvant therapy
therapeutic conventional surgery
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
American College of Radiology Imaging Network
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services